ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank33
3Y CAGR+9.6%
5Y CAGR+11.7%
Year-over-Year Change
Research and development spending
3Y CAGR
+9.6%/yr
vs -17.8%/yr prior
5Y CAGR
+11.7%/yr
Consistent
Acceleration
+27.4pp
Accelerating
Percentile
P33
Within normal range
vs 5Y Ago
1.7x
Solid growth
| Period | Value | YoY Change |
|---|---|---|
| TTM | $83.67M | 0.0% |
| 2025 | $83.67M | +17.9% |
| 2024 | $70.94M | +11.5% |
| 2023 | $63.62M | -4.0% |
| 2022 | $66.26M | +37.8% |
| 2021 | $48.10M | -59.7% |
| 2020 | $119.28M | -14.6% |
| 2019 | $139.62M | -21.3% |
| 2018 | $177.33M | -52.8% |
| 2017 | $376.01M | - |